| abstract |
This invention relates to compounds of formula (I) and pharmaceutical compositions thereof. Further, the present invention relates to a method of treating and/or preventing Aβ-related diseases such as Down's syndrome; β-type amylovascular disease such as, but not limited to, cerebral amylovascular disease or hereditary Cerebral hemorrhage; conditions associated with cognitive disorders such as, but not limited to, MCI ("mild cognitive impairment"), Alzheimer's disease, memory loss, attention related to Alzheimer's disease Insufficient symptoms, neurodegenerative diseases associated with diseases such as Alzheimer's disease, or dementia, including mixed angiogenic and degenerative dementia, Alzheimer's disease, Alzheimer's disease, and Parkinson's disease Related dementia; progressive nucleus or cortical basal ganglia degeneration. |